IN-VITRO ANTIBACTERIAL ACTIVITIES AND PRELIMINARY PHYTOCHEMICAL SCREENING OF THE AQUEOUS AND ETHANOLIC EXTRACTS OF ZINGIBER OFFICINALE

Size: px
Start display at page:

Download "IN-VITRO ANTIBACTERIAL ACTIVITIES AND PRELIMINARY PHYTOCHEMICAL SCREENING OF THE AQUEOUS AND ETHANOLIC EXTRACTS OF ZINGIBER OFFICINALE"

Transcription

1 Ife Jurnal f Science vl. 15, n. 1 (2013) 93 IN-VITRO ANTIBACTERIAL ACTIVITIES AND PRELIMINARY PHYTOCHEMICAL SCREENING OF THE AQUEOUS AND ETHANOLIC EXTRACTS OF ZINGIBER OFFICINALE Bashir, S.F., * A.H. Kaw, J.A. Bala and Y.U. Dabai Department f Micrbilgy, Faculty f Science, Department f Medical Labratry Science, Faculty f Medicine, Bayer University, PMB 3011, Kan, Nigeria 3 Department f Public Health and Preventive Medicine, Faculty f Medicine, Usmanu Danfdiy University, PMB 2346, Skt, Nigeria (*Crrespndence authr: ahkaw@yah.cm; ) (Received: March 2013; Accepted: April 2013) 1 2 ABSTRACT Studies n the in-vitr antibacterial activities and phytchemical screening f the aqueus and ethanlic extracts f Zingiber fficinale (ginger) against sme clinical bacterial islates (Escherichia cli, Staphylcccus aureus and Pseudmnas aeruginsa) btained frm ear and urine samples were carried ut using standard methds. Phytchemical screening revealed the presence f flavnids, sterids, tannins and reducing sugars in bth extracts while alkalids and sapnins were nly present in the ethanlic and aqueus extracts respectively. In additin, a cream, sft and dark-brwn ethanlic extract as well as slid, sft and black aqueus extract were recvered. The biassay studies shwed that the ethanlic extract exhibited an activity against S. aureus with 8 mm zne f inhibitin at a cncentratin f 1000 µg/disc while n activity was recrded against E. cli and P. aeruginsa at the same disc ptency. On the ther hand, the aqueus extract was fund t be mre active against E. cli with 9 mm zne f inhibitin at a cmparatively higher cncentratin f 3000 µg/disc. The minimum inhibitry cncentratin ranged between 250 and 6000 µg/ml. Overall, the results f the study shwed that the ethanlic and aqueus extracts f Z. fficinale have antibacterial ptentials against the tested clinical bacterial islates, thus supprting the plant's ethnmedicinal uses. Keywrds: Zingiber Officinale, Extracts, Phytchemistry, Antibacterial Activity, MIC. INTRODUCTION Plant-derived prducts have been used fr medicinal purpses fr centuries. At present, it is estimated that abut 80.0% f the wrld ppulatin relies n btanical preparatins as medicines t meet their health care needs. Herbs and spices are generally cnsidered safe and prved t be effective against certain ailments. They are als extensively used particularly in many Asian, African and ther cuntries (Langner et al, 1998). Herbal medicine, smetimes referred t as 'Herbalism' r 'Btanical medicine', is the use f herbs fr therapeutic r medicinal value. A herb is a plant r plant part valued fr its medicinal, armatic r savry qualities (Kaw et al., 2011). Herbaceus plants prduce and cntain a variety f chemical substances that act upn the bdy fr the cure f infectins f micrbial rigin. Many drugs cmmnly used tday are f herbal rigin. Indeed, abut 25% f the prescriptin drugs dispensed in the United States cntain at least ne active ingredient derived frm plant material. Sme are made frm plant extracts; thers are synthesized t mimic a natural plant cmpund (Reagr et al., 2002). Amng the plants used as herbal medicine is ginger (Zingiber fficinale). Ginger is a perennial herb which grws frm undergrund rhizmes, and is ften mistakenly called the "rts". Btanically, it is the rhizme that prvides its slightly ht, citrus-like taste, and wnderful arma. Its btanical name is Zingiber fficinale, riginating frm the plant family called Zingiberaceae (Aliyu, 2006). Ginger is ne f the mst imprtant and widely grwn perennial rhizmatus herbs with ver 90 species. It is mstly grwn in Suth-Eastern Asia extending t Queensland and Japan. Ginger is mainly used as a spice and t sme extent fr medicinal purpses (Langner et al., 1998). Ancient civilizatins in India and China used fresh ginger t treat nausea, asthma, cughs, clic, heart palpitatins, lss f appetite and rheumatism, fever, swelling, dysentery, diarrhea and sre (Aliyu, 2006). It has been fund t stimulate circulatin and imprve

2 94 Bashir et al.: In-Vitr Antibacterial Activities and Preliminary Phytchemical... bld flw and has been used fr centuries t aid in digestin, inhibit vmiting and prevent mtin r sea sickness. In India, ginger is used t prevent heart attacks and relieve migraine headaches. It has been fund t reduce chlesterl levels and lwer bld pressure. Ginger has als been fund t have antimicrbial prperties as it cntains extremely high levels f phytchemicals (plant substances with a healing effect) (Cakir et al., 2004). In additin t its beneficial effects n the heart and its anti-cancer activities, ginger has been reprted fr its anti-inflammatry effects and has high cntents f anti-xidants prperties (Aliyu, 2006). Thus, with respect t histrical and cultural recrds f varius medicinal plants and their applicatins as therapeutics, the present study aimed at determining the in-vitr antibacterial effects f the aqueus and ethanlic extracts f Z. fficinale as well as the phytchemical screening f the extracts t determine their biactive cmpnents with a view t further substantiate its ethn-medicinal ptentials. MATERIALS AND METHODS Cllectin, Identificatin and Preparatin f the Plant Materials Fresh ginger plant rhizme was purchased frm a lcal market in the metrplitan Kan, nrthern Nigeria. Its btanical identity was first authenticated at the field using standard keys and descriptins as reprted by Sfwra (1993) and Aliyu (2006). A further cnfirmatin and authenticatin f the plant at the herbarium sectin f the Department f Plant Science, Bayer University Kan, Nigeria was carried ut, where vucher specimens were preserved and stred fr future reference. The rhizme was thrughly washed with sterile distilled water and then allwed t air-dry fr few days. It was then grund int pwder frm using pestle and mrtar, sieved thrugh 250µm mesh t btain fine pwder which was stred at rm temperature in sealed cntainers until required fr use. Extractin Prtcls The extractin prtcls described by Fatpe et al (1993) were adpted. Tw different slvents were used in the extractin prcess: 95% ethanl and water. Here, 100 grams f the fine grunded pwder f the rhizme was taken and perclated with a liter (1000 ml) f ethanl t give a dilutin rati f 1:10. This was allwed t stand fr a perid f tw weeks with regular shaking using magnetic shaker. The cntent was then filtered using Whatman N. 1 filter paper and the filtrate btained was transferred int a pre-weighed beaker and then evaprated t dryness in a water bath at 30 C until the slvent escaped cmpletely leaving behind the ethanlic extract. This was then weighed t find the percentage yield f the extract. Similarly, anther 100 grams f the pwder was perclated with a litre f sterile distilled water in Kilner jar. This was als placed in the magnetic shaker t ensure regular shaking fr a perid f ne week. The aqueus perclatin was allwed fr nly ne week as leaving it t perclate fr mre than this perid may lead t fungal grwth n the surface f the slutin. The aqueus slutin was filtered using Whatman N. 1 filter paper, pured int a pre-weighed beaker and evaprated t dryness in a water bath at 30 C until the slvent escaped cmpletely leaving behind the aqueus extract nly. The percentage yield f the extracts was als determined. Phytchemical Screening f the Extracts Test fr Alkalids This was carried ut qualitatively accrding t Cuili (1994). Using a pipette, 1.0 ml f the aqueus r ethanlic extract was placed in tw separate test tubes. Using a drpper, three drps f Dragendff's and Meyer's reagents were separately added. An range-red precipitate r turbidity with Dragendff's reagent r white precipitate with Meyer's reagent was indicative f the presence f alkalids. Test fr Sapnins This was carried ut accrding t the methd reprted by Brain and Turner (1975). T 0.5 g f the aqueus r ethanlic extract in a test tube, 5.0 ml f sterile distilled water was added and shaken vigrusly. A frth that persisted fr 15 minutes was indicative f the presence f sapnins. Test fr Flavnids This was carried ut in accrdance with the

3 methd as reprted by Sfwra (1993). A 4 mg weight f the aqueus r ethanlic extract and a piece f magnesium ribbn were added fllwed by cncentrated HCl drp-wise. A clr change frm crimsn t magenta indicated the presence f flavnids in the extract. Test fr Sterids This was carried ut accrding t Cuili (1994). A 2 grams weight f the aqueus extract was taken in a test tube and evaprated t dryness. The extract was then disslved in acetic anhydride fllwed by the additin f chlrfrm and then cncentrated sulphuric acid was added by the side f the test tube. Appearance f a brwn ring at the interface f the tw liquids and the appearance f vilet clur in the supernatant layer indicated the presence f sterids in the extract. The same prcedure was fllwed fr the ethanlic extract. Test fr Tannins This was carried ut accrding t Cuili (1994). A 2 grams weight f the aqueus extract was diluted in sterile distilled water in a test tube. Then, 2-3 drps f 5% ferric chlride (FeCl 3) slutin were added. A green-black r blue-black cluratin was indicative f the presence f tannins in the extract. Same prcedure was adpted fr the ethanlic extract but using dimethylsulphxide (DMSO) as the diluent. Test fr Reducing Sugars This was carried ut accrding t the methd f Brain and Turner (1975). Here, ne gram each f the extracts was weighed and intrduced int separate test tubes. The ethanlic and aqueus extracts were diluted with 2.0 ml each f DMSO and sterile distilled water respectively. T the slutin thus btained were added Fehling's slutin and the mixture was then warmed. A brick-red precipitate at the bttm f the test tubes was indicative f the presence f reducing sugars in the extracts. Biassay Studies Bashir et al.: In-Vitr Antibacterial Activities and Preliminary Phytchemical... Cllectin, Identificatin and Authenticatin f Clinical Bacterial Islates The test rganisms (clinical bacterial islates) 95 included ne Gram-psitive bacterium (Staphylcccus aureus) and tw Gram-negative bacteria (Escherichia cli and Pseudmnas aeruginsa). They were cllected frm the Pathlgy Department f Murtala Mhammed Specialist Hspital (MMSH), Kan, Nigeria. Tw islates fr each species were cllected: ne islate frm urine sample and the ther frm ear swab. Identificatin and cnfirmatin f the islates was carried ut using the Gram's reactin, cultural, mrphlgical and bichemical tests (Chesebrugh, 2000). Preparatin f Extract-impregnated Paper Discs This was carried ut as described by Chesebrugh (2000). Here, discs f 6mm diameter were punched ut frm Whatman N.1 filter paper with the aid f paper puncher and placed int Biju bttles in batches f 100 discs. The discs were then sterilized by autclaving at 121 C fr 15 minutes and then allwed t cl. Preparatin f Extract Treatment Cncentratins Tw grams f ethanlic and aqueus extracts were each disslved in 2 ml f DMSO and water in separate Biju bttles t yield 1,000,000 µg/ml (1 g/ml) slutins f ethanlic and aqueus extracts respectively. These were labeled as ethanlic and aqueus stck slutins respectively. Frm the ethanlic extract stck slutin, 0.5 ml was measured and intrduced int a clean bttle cntaining 0.5 ml DMSO. This gave a cncentratin f 500,000 µg/ml. Then, 100 discs were added such that after even distributin (with the help f shaking at equilibrium) each disc absrbed 0.01 ml f the extract, which is equivalent t 5,000 µg/disc. Frm the same stck slutin, 0.4, 0.3, 0.2 and 0.1 ml was each pipetted int separate sterile bttles cntaining 0.6, 0.7, 0.8 and 0.9 ml f DMSO respectively. This was fllwed by the additin f 100 discs int each bttle such that each disc absrbed 0.01 ml f the slutin t arrive at cncentratins f 4000, 3000, 2000 and 1000 µg/disc respectively. These were stred in a refrigeratr at 4 C until required fr use. The same prcedure was repeated fr the

4 96 Bashir et al.: In-Vitr Antibacterial Activities and Preliminary Phytchemical... aqueus extract using sterile distilled water (Chesebrugh, 2000). Preparatin f Turbidity Standard and Standardizatin f Inculum The standard turbidity slutin (barium sulphate standard turbidity slutin) was prepared as described by Chesebrugh (2000). T 99 ml f sterile distilled water, 1 ml f cncentrated sulphuric acid (H SO ) was added t arrive at 1% 2 4 (v/v) slutin f the acid. A quantity (0.5 g) f barium chlride (BaCl.2H O: BDH) was 2 2 disslved in water until the final vlume f the slutin was 50 ml. Then, 0.6 ml f the barium chlride slutin was added t 99.4 ml f the 1% H SO slutin. This resulted in turbid slutin. A 2 4 small quantity f this turbid slutin was taken in a test tube, which served fr cmparisn during standardizatin f the incula. Fr standardizing the inculum, the test rganisms were subcultured nt nutrient agar (xid) plates and incubated at 37 C vernight after which perid an vernight clny was taken, transferred int a tube cntaining 2.0 ml f nrmal saline until the turbidity f the suspensin matched with the turbidity f the standard barium sulphate slutin. This was cnfirmed by cmparing the turbidity f the diluted inculum with that f the standard turbidity slutin against the backgrund f a printed white paper (where the inculum was mre turbid, a little mre nrmal saline was added until its turbidity matched with Macfarland standard f 3.30 x 10 cfu/ml). Susceptibility Testing f the Clinical Bacterial Islates This was carried ut using agar diffusin technique as described by Kirby-Bauer et al (1996). Here, nutrient agar (xid) plates were prepared and the surface f the agar was dried in a ht-air ven. Using sterile swab sticks, the nutrient agar plates were aseptically inculated with the test rganism. With the aid f sterile frceps and syringe, discs cntaining different cncentratins f the extract (5000, 4000, 3000, 2000 and 1000 µg/disc) were impregnated firmly n t the surface f inculated plates. Cntrl discs (30 µg/g chlramphenicl as a psitive cntrl while DMSO was used as a negative cntrl) were als incrprated nt the inculated plates. The discs were sufficiently spaced ut t prevent verlapping f the znes. The plates were then allwed fr the pre-diffusin time f 15 minutes after which they were incubated at 37±1 C fr 24 hurs. Diameters f znes f inhibitin were measured using millimeter rule and the results expressed in mm. Determinatin f the Minimum Inhibitry Cncentratin This was carried ut in accrdance with the methds described by Mrell et al. (2003) and Barnett (1992). Extract cncentratins f 2000, 1000, 500 and 250 µg/ml were prepared. A quantity (0.1 ml) f the suspensin f the test bacterium was inculated nt fresh nutrient agar (xid) plates at the different extract cncentratins. The plates were incubated at 37±1 C fr hurs. The lwest cncentratin f the extract that inhibited the grwth f the test bacterium was nted and recrded as the minimum inhibitry cncentratin (MIC). RESULTS Physical and Phytchemical Characteristics f the Extracts The results f the physical characteristics f the extracts shwed that yields f 9.2 and 8.6 grams f the aqueus and ethanlic extracts were btained respectively. The aqueus extractin was black, pungent, sft and slid while the ethanlic was dark-brwn, pungent, sft and creamy (Table 1). Table 1: Physical Characteristics f Ethanlic and Aqueus Extracts f Zingiber fficinale Extract Initial Final Clur Odur Texture Appearance weight (g) weight (g) Ethanlic Dark- Pungent Sft Creamy brwn Aqueus Black Pungent Oily Slid

5 Bashir et al.: In-Vitr Antibacterial Activities and Preliminary Phytchemical... Results f the phytchemical screening f the extracts shwed the presence f flavnids, sterids, tannins and reducing sugars in bth the aqueus and ethanlic extracts while alkalids and sapnins were nly present in the ethanlic and aqueus extracts respectively (Table 2). Table 2: Phytchemical Characteristics f Aqueus and Ethanlic Extracts f Z. Officinale Extract Alkalids Sapnins Flavnids Sterids Tannins Reducing sugar Ethanlic Aqueus KEY: + = present - = absent The results f the biassay studies shwed that the ethanlic extract was active nly at cncentratin f 1000 µg/disc and the activity was prnunced n S. aureus II while fr S. aureus I, the activity started at 4000 µg/disc. The ethanlic extract was fund t be active against P. aeruginsa II nly at 2000 µg/disc and at 3000 µg/disc against P. aeruginsa I while it was fund t be active at cncentratin f 4000 µg/disc against E. cli II and inactive at all at all cncentratins against E. cli I (Table 3). Table 3: Antibacterial Activities f the Ethanlic Extract f Zingiber Officinale Cncentratin f discs (µg/disc) Islates Psitive cntrl Negative cntrl Diameter f zne f inhibitin (mm) E. cli I E. cli II S. aureus I S. aureus II P. aeruginsa I P. aeruginsa II KEY: E. cli I, P. aeruginsa I and S. aureus 1 are islates btained frm urine samples. E. cli II, P. aeruginsa II and S. aureus II are islates btained frm ear swabs. The aqueus extract had its lwest activity at 3000 µg/disc, but it was mre prnunced against E. cli II with 9 mm zne f inhibitin while n E. cli I, there was n activity at all cncentratins. On S. aureus I and II, the extract was active at 4000 µg/disc with 8 mm zne f inhibitin each while n bth P. aeruginsa I and II, 3000 µg/disc was active with 8 mm zne f inhibitin each (Table 4). Table 4: Antibacterial Activities f the Aqueus Extract f Zingiber Officinale Cncentratin f discs (µg/disc) Islates Psitive cntrl Negative cntrl Diameter f zne f inhibitin (mm) E. cli I E. cli II S. aureus I S. aureus II P. aeruginsa I P. aeruginsa II KEY: E. cli I, P. aeruginsa I and S. aureus I are islates btained frm urine samples. E. cli II, P. aeruginsa II and S. aureus II are islates btained frm ear swabs.

6 98 Bashir et al.: In-Vitr Antibacterial Activities and Preliminary Phytchemical... Results f the minimum inhibitry cncentratins (MICs) f the ethanlic extract n the test rganisms were 4000, 8000, 250, 6000 and 4000 µg/ml against E. cli II, S. aureus I, S. aureus II, P. aeruginsa I and P. aeruginsa II respectively. Fr the Table 5: MICs f the Aqueus and Ethanlic Extracts f Zingiber Officinale Islates Aqueus extract (µg/ml) Ethanlic extract (µg/ml) E. cli II S. aureus I S. aureus II P. aeruginsa I P. aeruginsa II aqueus extract, the MICs fr E. cli II, S. aureus I, S. aureus II, P. aeruginsa I and P. aeruginsa II were 3000, 4000, 3000, 6000 and 3000 µg/ml respectively (Table 5). KEY: E. cli I, P. aeruginsa I and S. aureus I are islates btained frm urine samples. E. cli II, P. aeruginsa II and S. aureus II are islates btained frm ear swab. DISCUSSION The activities f the aqueus and ethanlic extracts f Z. fficinale against the bacterial islates in this study culd be attributed t the presence f the biactive ingredients such as alkalids, tannins and sapnins in the extracts. These cmpunds have been reprted t have exhibited antibacterial ptentials (Fatpe et al., 1993; Cakir et al., 2004; Kaw et al., 2011). Accrding t the present study, preparing an extract with rganic slvent such as alchl has been shwn t have exhibited a better antibacterial activity. This is in accrdance with the results earlier reprted by Kwa et al (2012) wh reprted ethanl as the best slvent that disslves multivariable type f cmpunds. The effectiveness f the rganic slvent (ethanl) might be attributed t tw reasns: firstly, the nature f bilgically-active cmpnents; their activities culd be enhanced in the presence f rganic slvents. Secndly, the strength f the extractin capacity f the ethanl culd have allwed mre f the biactive cnstituents respnsible fr the antibacterial activities. On the ther hand, the ethanlic extract was fund t be mre active against the Gram-psitive islates (S. aureus) while the aqueus extract was fund t be mre active against the Gram-negative islates (P. aeruginsa and E. Cli). This variability culd be related t the ability f the different slvents t disslve sme f the chemical cnstituents in the extracts. Hwever, the resistance f E. cli I t bth extracts (Tables 3 and 4) culd be attributed t the presence f phytchemicals that have pr slubility in the gut as reprted in Table 2 r the antibitics taken by the patient(s) frm which it was islated; as such it culd have develped resistance t such antibitics and becme a resistant strain (Kubmarawa et al., 2008; Kumurya et al., 2010). It culd als be as a result f crss resistance that might have been develped by the bacterium. The findings f the present study have shwn that the islates btained frm the ear swabs exhibited a greater susceptibility t the extracts than thse btained frm the urine samples. This bservatin culd be attributed t the fact that the rganisms frm urine (E. cli I, S. aureus I and P. aeruginsa I) might have been subjected t varius drugs and antibitics than thse frm the ear swabs (E. cli II, S. aureus II and P. aeruginsa II). In additin, the kidney, which acts as an imprtant rgan fr excreting the urine, is als invlved in metablizing drugs and antibitics taken up by a patient. Thus, resistance culd be develped by such rganisms. On the ther hand, the rganisms frm the ear swabs culd be less subjected t antibitics unless in rare cases, hence might nt develp such a resistance. CONCLUSIONS AND RECOMMENDATIONS The results btained in this study justify the ppularity enjyed by this plant and it als

7 ratinalizes the use f the plant fr the treatment f cutaneus and gastr-intestinal infectins. The range f bacteria inhibited suggests that the plant culd be used in the treatment f respiratry and urinary tract as well as wund infectins. The high vulnerability f P. aeruginsa t the extracts tested in this study is wrthy f nte as this bacterium is resistant t mst f the available disinfectants and antibitics (Neu, 1983; Timasz, 1994). It is therefre recmmended that further research needs t be carried ut using ther slvents t ascertain the antibacterial ptentials f the extracts. In additin, there is need t islate, purify and characterize these phytchemical cnstituents respnsible fr the bserved biactivities with a view t supplementing cnventinal drug develpment and/r prbably serve as lead cmpunds fr varius pharmaceuticals especially in develping cuntries like Nigeria. Finally, it wuld be wrthwhile t establish the txiclgical prperties f ginger by determining its minimum lethal dse (LC ). 50 REFERENCES Bashir et al.: In-Vitr Antibacterial Activities and Preliminary Phytchemical... Aliyu, B.S Cmmn ethn-medicinal plants f the semiarid regins f West Africa their descriptins and phytchemicals Triumph publishing cmpany Limited, Gidan Sa'adu Zungur, Kan, Nigeria. Barnett, M.E Micrbilgy Labratry Exercises. Wm. C. Brwn publishers, United States f America. Brain, K.R. and Turner, T.D Practical Evaluatin f Phyt-pharmaceuticals. Wright Scientechica,Bristl, United Kingdm. pp Cakir, A., Krdali, S., Zengin, H., Izumi, S. and Hirata, T Cmpsitin and antifungal activity f essential il islated frm Hypericum husspiflium and Hypericum heterrphyllum. Flavur and Fragrance Jurnal 19: Chesebrugh, M Medical Labratry Manual fr Trpical Cuntries Vlume II. Secnd editin, University Press, Cambridge, Great Britain, 377pp. Cuilel, I Methdlgy fr the Analysis f Vegetables and Drugs. Chemical Industry Divisin, NNIDO Rmania. pp Fatpe, M.O., Ibrahim, H. and Takeda, Y Screening f higher plants reputed as pesticides using the brine shrimp lethality assay. Internatinal Jurnal f Pharmacgnsy 31: Kaw, A.H., Suleiman, Z.A. and Yusha'u, M Studies n the antibacterial activities and chemical cnstituents f Khaya senegalensis and Ximenia americana leaf extracts. African Jurnal f Micrbilgy Research 5(26): Kirby, W.M., Bauer, A.W., Sherris, J.C. and Tutccch, M.C Antibitic susceptibility testing by a standardized single disc methd. American Jurnal f Clinical Pathlgy 45: Kubmarawa, D., Khan, M.E., Punah, A.M. and Hassan, M Phytchemical screening and antimicrbial efficacy f extracts frm Khaya senegalensis against human pathgenic bacteria. African Jurnal f Bitechnlgy 7(24): Kumurya, A.S., Kaw, A.H. and Uba, A Prevalence and in-vitr susceptibility studies f bacteria islated frm hspital patients presenting with titis media in Kan, Nigeria. Bilgical and Envirnmental Sciences Jurnal fr the Trpics 7(1): Kwa, A.M., Kaw, A.H. and Indabawa, I.I. (2012): Phytchemical screening and antibacterial activities f the aqueus and ethanlic extracts f the stem-bark and leaves f Bauhinia rufescens. Internatinal Jurnal f Bimedical and Health Sciences 8(1): Langner, E., Greifenberg, S. and Gruenwald, J Ginger: Histry and use. Advanced Therapy 15(1): Mrell, J.A., Mizer, H.E. and Granat, P.A Labratry Manual and Wrkbk in Micrbilgy: th Applicatin t Patient Care. 7 editin, McGraw- Hill cmpanies, New Yrk, USA. Neu, H.C The rle f Pseudmnas aeruginsa in infectins. Jurnal f Antimicrbials and Chemtherapy 11:1-13. Reagr, L., Gusman, J., McCy, L., Carin, E. and Heggers, J.P The effectiveness f related grape fruit-seed extract as an antibacterial agent I: An in-vitr agar assay. Jurnal f Alternative and Cmplementary Medicine 8: Sfwra, A Medicinal Plants and Traditinal Medicine in Africa. Spectrum bks l i m i t e d, Ibadan, Nigeria. pp Timasz, A Multiple-antibitic-resistant pathgenic bacteria: A reprt n the Rckefeller University Wrkshp. New England Jurnal f Medicine 330:

ANTIMICROBIAL ACTIVITY OF AQUEOUS & METHANOLIC EXTRACT OF YOUNG & MATURE LEAVES OF PSIDIUM GUAJAVA L. (GUAVA)

ANTIMICROBIAL ACTIVITY OF AQUEOUS & METHANOLIC EXTRACT OF YOUNG & MATURE LEAVES OF PSIDIUM GUAJAVA L. (GUAVA) J. Indian bt. Sc. Vl. 92 (1&2) 2013 : 4751 ANTIMICROBIAL ACTIVITY OF AQUEOUS & METHANOLIC EXTRACT OF YOUNG & MATURE LEAVES OF PSIDIUM GUAJAVA L. (GUAVA) MEENAKSHI VAIDYA Department f Btany, Mithibai Cllege,

More information

erythromycin, clindamycin, gentamicin,

erythromycin, clindamycin, gentamicin, JMBR: A Peer-review Jurnal f Bimedical Sciences December 2015, Vl. 14 N. 2 pp 88-95 COMBINATION OF AGERATUM CONYZOIDES LEAF EXTRACTS WITH ANTIBIOTICS AGAINST STAPHYLOCOCCUS AUREUS AND PSEUDOMONAS AERUGINOSA

More information

ABIOpure TM Total RNA (version 2.0)

ABIOpure TM Total RNA (version 2.0) ABIOpure TM Ttal RNA (versin 2.0) Bld Extractin Handbk Cat N: M541RP50-B FOR RESEARCH USE ONLY Table f Cntents Cntents Page Kit Cmpnents 3 Precautins 3 Stability & Strage 4 General Descriptin 4 Limitatins

More information

FDA Dietary Supplement cgmp

FDA Dietary Supplement cgmp FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes

More information

VITAPRO. Detoxification properties of Apple pectin formulation, PROPECTIN. CENTRE D ETUDE ET DE VALORISATION DES ALGUES FINAL REPORT.

VITAPRO. Detoxification properties of Apple pectin formulation, PROPECTIN. CENTRE D ETUDE ET DE VALORISATION DES ALGUES FINAL REPORT. CENTRE D ETUDE & DE VALORISATION DES ALGUES 2400 Detxificatin prperties f Apple pectin frmulatin, PROPECTIN. VITAPRO FINAL REPORT PrPectin July 2015 CENTRE D ETUDE ET DE VALORISATION DES ALGUES PRESQU

More information

Dosage Administration

Dosage Administration Pharmacy Technician Dsage Administratin Dsage Administratin Dsage Frms and Their Usages Medicatins ften cnsist f small quantities f active ingredients cmbined with inactive ingredients t create varius

More information

Influence of Endosperm Type On the Nutritive Value Of Grain Sorghum and Corn

Influence of Endosperm Type On the Nutritive Value Of Grain Sorghum and Corn Influence f Endsperm Type On the Nutritive Value Of Grain Srghum and Crn c. A. Hibberd, R. Schemm and D. G. Wagner Stry in Brief The nutritive value f several varieties f grain srghum and crn was studied

More information

PROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon

PROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon PROTOCOL Cmplex II Enzyme Activity Micrplate Assay Kit 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 MS241 Rev.0 DESCRIPTION Cmplex II Enzyme Activity Micrplate Assay Kit Sufficient materials are prvided

More information

ESCHERICHIA COLI. By: Breana Williams

ESCHERICHIA COLI. By: Breana Williams ESCHERICHIA COLI By: Breana Williams DISEASE OVERVIEW Escherichia cli (E. cli) are bacteria that can be fund in the intestines f humans and animals alng with in the envirnment and in fd. There are many

More information

CDC Influenza Division Key Points MMWR Updates February 20, 2014

CDC Influenza Division Key Points MMWR Updates February 20, 2014 CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February

More information

Annex E Terms of Reference: Therapeutic use

Annex E Terms of Reference: Therapeutic use Annex E Terms f Reference: Therapeutic use The purpse f the pre-review reprt is t synthesize existing scientific evidence abut the therapeutic use and ptential fr dependence and abuse f cannabisrelated

More information

Tick fever is a cattle disease caused by any one of the following blood parasites:

Tick fever is a cattle disease caused by any one of the following blood parasites: Tick fever Tick fever is a cattle disease caused by any ne f the fllwing bld parasites: Babesia bvis Babesia bigemina Anaplasma marginale These parasites are all transmitted by the cattle tick (Bphilus

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is

More information

PROTOCOL. SOD2 Protein Quantity Microplate Assay Kit. MS746 Rev.0 DESCRIPTION INTRODUCTION

PROTOCOL. SOD2 Protein Quantity Microplate Assay Kit. MS746 Rev.0 DESCRIPTION INTRODUCTION PROTOCOL SOD2 Prtein Quantity Micrplate Assay Kit 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 MS746 Rev.0 DESCRIPTION SOD2 Prtein Quantity Micrplate Assay Kit Sufficient materials are prvided fr

More information

Protocol. Preparation Protocol for the Non-Targeted Vevo MicroMarker Contrast Agent

Protocol. Preparation Protocol for the Non-Targeted Vevo MicroMarker Contrast Agent Prtcl Preparatin Prtcl fr the Nn-Targeted Vev MicrMarker Cntrast Agent System Cmpatibility: This guide cntains instructins and suggestins fr wrk n the Vev2100, VevLAZR, Vev 3100 systems and transducers

More information

Name: Date: Period: Notes: The Blood and Lymphatic System

Name: Date: Period: Notes: The Blood and Lymphatic System Name: Date: Perid: Cmpsitin f Bld and their Functins Red Bld Cells (aka ) Structure Ntes: The Bld and Lymphatic System D nt have a like ther cells d Cntain a specialized prtein called Hemglbin cntains

More information

A fake medicine that passes itself off as a real, authorised medicine. (1)

A fake medicine that passes itself off as a real, authorised medicine. (1) Falsified medicines Index 1 Intrductin 2 Types f falsified medicines 3 Eurpean regulatin n falsified medicines 4 Risks f falsified medicines 5 Buying medicine nline safely 6 References 7 Further resurces

More information

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...

More information

PHYTOCHEMICAL, TOXICOLOGICAL AND HISTOPATHOLOGICAL OF SOME MEDICINAL PLANTS IN NIGERIA

PHYTOCHEMICAL, TOXICOLOGICAL AND HISTOPATHOLOGICAL OF SOME MEDICINAL PLANTS IN NIGERIA Internatinal Jurnal f Natural and Applied Sciences, 2(3): 22-229, 2006 ~apas Institute f Scientific Research and Develpment, 2006 PHYTOCHEMICAL, TOXICOLOGICAL AND HISTOPATHOLOGICAL OF SOME MEDICINAL PLANTS

More information

REVISION: PHOTOSYNTHESIS & CELLULAR RESPIRATION 18 JUNE 2014

REVISION: PHOTOSYNTHESIS & CELLULAR RESPIRATION 18 JUNE 2014 REVISION: PHOTOSYNTHESIS & CELLULAR RESPIRATION 18 JUNE 2014 Lessn Descriptin In this lessn, we revise: the prcess f phtsynthesis the prcesses invlved in cellular respiratin Summary Phtsynthesis (Slutins

More information

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride

More information

Improving Surveillance and Monitoring of Self-harm in Irish Prisons

Improving Surveillance and Monitoring of Self-harm in Irish Prisons HSE Mental Health Divisin Stewart s Hspital, Palmerstwn, Dublin 20 Tel: 01 6201670 Email: inf@nsp.ie www.nsp.ie Imprving Surveillance and Mnitring f Self-harm in Irish Prisns Prject Scpe Dcument 8 th June

More information

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps. NAU Mdel Observatin Prtcl The mdel prtcl was develped with supprt and expertise frm the Natinal Institute fr Excellence in Teaching (NIET) and is based in great part n NIET s extensive experience cnducting

More information

SECTION O. MEDICATIONS

SECTION O. MEDICATIONS SECTION O. MEDICATIONS 1. NUMBER OF MEDICA TIONS (Recrd the number f different medicatins used in the last 7 days; enter "0" if nne used) O1. Number f Medicatins (7-day lk back) Intent: Prcess: Cding:

More information

You may have a higher risk of bleeding if you take warfarin sodium tablets and:

You may have a higher risk of bleeding if you take warfarin sodium tablets and: MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain

More information

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP MEDICATION GUIDE Piglitazne (pie-h-glit-ah-zhn) and Metfrmin (met-fore-min) Hydrchlride Tablets USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride tablets

More information

Herbal Medicines: Traditional Herbal Registration

Herbal Medicines: Traditional Herbal Registration Herbal Medicines: Traditinal Herbal Registratin In the UK, cmpanies can nly sell herbal medicines with the apprpriate prduct licence, as fllws: A full marketing authrisatin based n the safety, quality

More information

Further Studies on the Influence of Steroids on

Further Studies on the Influence of Steroids on INFECTION AND IMMUNITY, Aug. 1973, p. 151-155 Cpyright ( 1973 American Sciety fr Micrbilgy Vl. 8, N. 2 Printed in U.S.A. Further Studies n the Influence f Sterids n Viral Infectin in Mice D. J. GIRON,

More information

BIODIVERSITY & CLASSIFICATION OF MICRO-ORGANISMS 05 FEBRUARY 2014

BIODIVERSITY & CLASSIFICATION OF MICRO-ORGANISMS 05 FEBRUARY 2014 BIODIVERSITY & CLASSIFICATION OF MICRO-ORGANISMS 05 FEBRUARY 2014 In this lessn we: Lessn Descriptin Lk at the basic structures and general characteristics f micr rganisms Discuss the rle f micr-rganisms

More information

BIOLOGY 101. CHAPTER 7: Membrane Structure and Function: Life at the Edge

BIOLOGY 101. CHAPTER 7: Membrane Structure and Function: Life at the Edge BIOLOGY 101 CHAPTER 7: Membrane Structure and Functin: Life at the Edge Membrane Structure and Functin: Life at the Edge CONCEPTS: 7.1 Cellular membranes are fluid msaics f lipids and prteins 7.2 Membrane

More information

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights. HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,

More information

M.J. Guthriel, D.G. Wagner2

M.J. Guthriel, D.G. Wagner2 EFFECT OF SUPPLEMENTAL PROTEIN OR GRAIN ON INTAKE AND UTILIZATION OF MEDIUM QUALITY PRAIRIE HAY BY STEERS M.J. Guthriel, D.G. Wagner2 and D.C. Weakley3 Stry in Brief Sixteen 1,053 lb tw-year-ld Herefrd

More information

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by ESTIMATION PROCEDURES USED TO PRODUCE WEEKLY FLU STATISTICS FROM THE HEALTH INTERVIEW SURVEY James T. Massey, Gail S. Pe, Walt R. Simmns Natinal Center fr Health Statistics. INTRODUCTION In April 97, the

More information

Refining Blood Collection Techniques to Improve Animal Welfare and Sample Quality

Refining Blood Collection Techniques to Improve Animal Welfare and Sample Quality Refining Bld Cllectin Techniques t Imprve Animal Welfare and Sample Quality Amy Allaire RLATG 1, Jennifer Jhnsn 2, Kimberly Maratea DVM PhD 2, Steven Bulé CMAR RLATG 1, Sara Savage DVM DACLAM 1 1 Dispsitin,

More information

Pain relief after surgery

Pain relief after surgery Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read

More information

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this

More information

The Cannabis Act and Regulations

The Cannabis Act and Regulations The and Regulatins OVERVIEW The and Regulatins cme int frce n Octber 17, 2018 and replaces the Access t Cannabis fr Medical Purpses Regulatins (ACMPR), and any mentin f Cannabis and Marihuana in the Narctics

More information

STUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM

STUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM Published Online: 1 June, 1936 Supp Inf: http://di.rg/1.184/jem.63.6.83 Dwnladed frm jem.rupress.rg n August 13, 218 STUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM BY T. P. MAGILL,

More information

Percutaneous Nephrolithotomy (PCNL)

Percutaneous Nephrolithotomy (PCNL) Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this

More information

Technology to overcome challanges

Technology to overcome challanges Technlgy t vercme challanges MORE THAN 25 YEARS DEVELOPING SOLUTIONS Przyn is a cmpany specialized in enzymes slutins and biingredients applicatins, ver 25 years f experience in develping bitechnlgy slutins.

More information

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.

More information

BLOOD BORNE PATHOGENS

BLOOD BORNE PATHOGENS BLOOD BORNE PATHOGENS GALVESTON ISD ANNUAL TRAINING 2018-2019 Galvestn Independent Schl District Special Prgrams/ECH Health Services Required Training Ò Training is required by the Texas Department f Health

More information

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol. SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

CDC Influenza Division Key Points November 7, 2014

CDC Influenza Division Key Points November 7, 2014 In this dcument: Summary Key Messages FluView Activity Update LAIV Effectiveness and Vaccinatin f Children H3N2 Match and Vaccinatin Vaccine Supply Summary Key Messages This week s FluView reprt indicates

More information

Chapter 6: Impact Indicators

Chapter 6: Impact Indicators Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the

More information

Monensin and Extruded Urea-Grain for Range Beef Cows

Monensin and Extruded Urea-Grain for Range Beef Cows Mnensin and Extruded Urea-Grain fr Range Beef Cws R. P. Lemenager, F. N. Owens, w. E. Sharp, Merwin Cmptn and Rbert Ttusek Stry in Brief Tw trials were cnducted t evaluate the supplemental value f mnensin

More information

INTRODUCTION TO THE CIRCULATORY SYSTEM

INTRODUCTION TO THE CIRCULATORY SYSTEM INTRODUCTION TO THE CIRCULATORY SYSTEM What des bld d? 5. What makes this pssible? : In rder fr there t be an efficient exchange f xygen, waste and nutrients there must be a high surface area between the

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

Ruminal Availability of Phosphorus and Its Effect on Digestion

Ruminal Availability of Phosphorus and Its Effect on Digestion Table 2. Trial results Cncentratin f Captan,ppm liem 0 160 320 640 Dry matter digestibility (%) Ruminal 65.1 72.8 69.4 74.3 Ttal 82.1 81.9 82.4 82.0 Starch digestin (%) Ruminal 87.7 93.6 89.3 92.2 N digestibility

More information

CDC Influenza Technical Key Points February 15, 2018

CDC Influenza Technical Key Points February 15, 2018 CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems. PATIENT INFORMATION capsules, fr ral use fr ral suspensin What is TAMIFLU? TAMIFLU is a prescriptin medicine used t: treat the flu (influenza) in peple 2 weeks f age and lder wh have had flu symptms fr

More information

The demonstration of lysosomes by the controlled temperature freezing-sectioning method By LUCILLE BITENSKY

The demonstration of lysosomes by the controlled temperature freezing-sectioning method By LUCILLE BITENSKY 205 The demnstratin f lyssmes by the cntrlled temperature freezing-sectining methd By LUCILLE BITESKY (Frm the Department f Pathlgy, Ryal Cllege f Surgens f England, Lincln's Inn Fields, Lndn, W.C. 2)

More information

METHOD 8032 ACRYLAMIDE BY GAS CHROMATOGRAPHY

METHOD 8032 ACRYLAMIDE BY GAS CHROMATOGRAPHY METHOD 8032 ACRYLAMIDE BY GAS CHROMATOGRAPHY 1.0 SCOPE AND APPLICATION 1.1 Methd 8032 is used t determine trace amunts f acrylamide mnmer in aqueus matrices. This methd may be applicable t ther matrices.

More information

STANDARD FOR POMEGRANATE (CODEX STAN )

STANDARD FOR POMEGRANATE (CODEX STAN ) CODEX STAN 310-2013 Page 1 f 5 1. DEFINITION OF PRODUCE STANDARD FOR POMEGRANATE (CODEX STAN 310-2013) This Standard applies t fruits f cmmercial varieties f pmegranates grwn frm Punica granatum L., f

More information

This information shows what new challenges are likely to require prevention efforts moving forward.

This information shows what new challenges are likely to require prevention efforts moving forward. Release f CDC s Healthcare-Assciated Infectins (HAI) Pint Prevalence Survey and Annual Natinal and State HAI Prgress Reprt Embarged until: Wednesday, March 26 th at 12 nn ET Key Messages Overall These

More information

Statement of Work for Linked Data Consulting Services

Statement of Work for Linked Data Consulting Services A. Backgrund Infrmatin Statement f Wrk fr Linked Data Cnsulting Services The Natinal Library f Medicine (NLM), in Bethesda, Maryland, is a part f the Natinal Institutes f Health, US Department f Health

More information

The Shea Supply Chain and its Value in Confectionery Products. GSA New York May 2014

The Shea Supply Chain and its Value in Confectionery Products. GSA New York May 2014 The Shea Supply Chain and its Value in Cnfectinery Prducts. GSA New Yrk May 2014 IOI Lders Crklaan is part f IOI Grup Prperty develpment Oil palm plantatins Olechemicals Edible Oils (including IOI Lders

More information

Reliability and Validity Plan 2017

Reliability and Validity Plan 2017 Reliability and Validity Plan 2017 Frm CAEP The principles fr measures used in the CAEP accreditatin prcess include: (a) validity and reliability, (b) relevance, (c) verifiability, (d) representativeness,

More information

PATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to:

PATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to: PATIENT INFORMATION Rsuvastatin Calcium (re-soo-va-stat-in KAL-see-um) Tablets Read this Patient Infrmatin carefully befre yu start taking rsuvastatin calcium tablets and each time yu get a refill. If

More information

MEDICATION GUIDE. (fingolimod) capsules

MEDICATION GUIDE. (fingolimod) capsules MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the

More information

Appendix 1 Example of Homely Remedy Policy

Appendix 1 Example of Homely Remedy Policy Appendix 1 Example f Hmely Remedy Plicy Hmely Remedy Plicy - EXAMPLE This plicy applies t (insert name f Care Hme) Definitin A hmely (r husehld) remedy is a medicinal prduct fr the shrt-term treatment

More information

Referral Criteria: Inflammation of the Spine Feb

Referral Criteria: Inflammation of the Spine Feb Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses

More information

Methadone Maintenance Treatment for Opioid Dependence

Methadone Maintenance Treatment for Opioid Dependence POLICY STATEMENT Methadne Maintenance Treatment fr Opiid Dependence APPROVED BY COUNCIL: May 2010 PUBLICATION DATE: Dialgue, Issue 2, 2010 Disclaimer: As f May 19, 2018 physicians n lnger require an exemptin

More information

Forensic Science: Fundamentals & Investigations, 2e Chapter 9. All rights Reserved Cengage/NGL/South-Western 2016

Forensic Science: Fundamentals & Investigations, 2e Chapter 9. All rights Reserved Cengage/NGL/South-Western 2016 1 Frensic Science: Fundamentals & Investigatins, 2e Cengage/NGL/Suth-Western 2016 Frensic Txiclgy By the end f this chapter yu will be able t: 9.1 Prvide examples f drugs, pisns, and txins. 9.2 List factrs

More information

What s your diagnosis? Signlament: 11 y MC Maltese Mix. Presenting complaint: Pollakiuria with hematuria.

What s your diagnosis? Signlament: 11 y MC Maltese Mix. Presenting complaint: Pollakiuria with hematuria. What s yur diagnsis? Signlament: 11 y MC Maltese Mix Presenting cmplaint: Pllakiuria with hematuria. Histry: Zippy presented with a 4 day histry f pllakiuria. Straining t urinate had nt been nted, hwever

More information

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation RActemra (tcilizumab) fr Giant Cell Arteritis (GCA) subcutaneus (SC) frmulatin What yu shuld knw abut RActemra This brchure prvides key infrmatin t assist in the patient s understanding f the benefits

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment

More information

ALCAT FREQUENTLY ASKED QUESTIONS

ALCAT FREQUENTLY ASKED QUESTIONS 1. Is fasting required befre taking the Alcat Test? N. It is recmmended t drink water and t avid stimulants like caffeine prir t the test. 2. With regard t testing children, must a child be a certain age

More information

H1N1 Influenza 09 Guidance for Residential Aged Care

H1N1 Influenza 09 Guidance for Residential Aged Care H1N1 Influenza 09 Guidance fr Residential Aged Care 11 June 2009 As knwledge abut H1N1 Influenza 09 develps, further advice will be prvided. Please check www.healthemergency.gv.au fr the latest infrmatin.

More information

CONSUMER MEDICINE INFORMATION

CONSUMER MEDICINE INFORMATION CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers sme cmmn questins abut CEFTRIAXONE lcp. It des nt cntain all the available infrmatin. It des nt take the place f talking t yur

More information

ACMPR - Access to Cannabis for Medical Purposes Regulations Part 1 Commercial Production

ACMPR - Access to Cannabis for Medical Purposes Regulations Part 1 Commercial Production - Access t Cannabis fr Medical Purpses Regulatins Part 1 Cmmercial Prductin September 2017 OVERVIEW Yu must cmply with regulatins t supply medical cannabis as f August 24, 2016 There are fur parts t the

More information

EURL-SRM - Analytical Observations Report

EURL-SRM - Analytical Observations Report cncerning the fllwing EURL-SRM - Analytical Observatins Reprt Cmpund(s): Pymetrzine Cmmdities: Varius cmmdities f plant rigin Methd(s): QuEChERS, adjustment f ph Instrumentatin: LC-MS/MS Analysis f Pymetrzine

More information

PACKAGE LEAFLET INFORMATION FOR THE PATIENT

PACKAGE LEAFLET INFORMATION FOR THE PATIENT PACKAGE LEAFLET INFORMATION FOR THE PATIENT AMPICILLIN 125mg/5ml and 250mg/5ml ORAL SUSPENSION Please read all f this leaflet carefully befre yu start taking this medicine because it cntains imprtant infrmatin

More information

Sugar Rush: The Science of Sweet

Sugar Rush: The Science of Sweet Sugar Rush: The Science f Sweet FRAMEWORK I. Scientific and Engineering Practices II. Crss-Cutting Cncepts III. Physical Sciences SKILLS/OBJECTIVES T bserve the results f hands-n experiments and make inferences/draw

More information

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher:

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher: Year 10 Fd Technlgy Assessment Task 1: Fds fr Special Needs Name: Teacher: Due Date: Term 2, Week 1 Type f Task: Design Task Planning Fd Requirements Cllectin f Assessment: Submit in Class Assessment Plicy:

More information

(From the Laboratories of the International Health Division of The Rockefeller Foundation, New York)

(From the Laboratories of the International Health Division of The Rockefeller Foundation, New York) THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION BY GEORGE K. HLRST, M.D. (Frm the Labratries f the Internatinal Health Divisin f The Rckefeller Fundatin,

More information

Effect of Stage of Maturity on the Chemical Composition and In Vitro Digestibility of Sorghum Grain

Effect of Stage of Maturity on the Chemical Composition and In Vitro Digestibility of Sorghum Grain Effect f Stage f Maturity n the Chemical Cmpsitin and In Vitr Digestibility f Srghum Grain C.A. Hibberd, D.G. Wagner and R.L. Hintz Stry in Brief Dwarf Redlan (waxy), Redlan (nrmal) and Darset (bird-resistant)

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe

More information

SUICIDE AND MENTAL ILLNESS IN SINGAPORE

SUICIDE AND MENTAL ILLNESS IN SINGAPORE Vl. 15, N. 3. SINGAPORE MEDICAL JOURNAL 191 September, 1974. SUICIDE AND MENTAL ILLNESS IN SINGAPORE By W. F. Tsi and B. H. Chia SYNOPSIS This is a study f 112 cases f suicides wh had a past histry f being

More information

NFS284 Lecture 3. How much of a nutrient is required to maintain health? Types and amounts of foods to maintain health

NFS284 Lecture 3. How much of a nutrient is required to maintain health? Types and amounts of foods to maintain health NFS284 Lecture 3 Chapter 2: Nutritin: Guidelines: Applying the Science f Nutritin 2.1 Nutritin Recmmendatin fr the Canadian Diet Nutrient-based apprach Hw much f a nutrient is required t maintain health?

More information

Influenza (Flu) Fact Sheet

Influenza (Flu) Fact Sheet Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder

More information

Administrstrative Procedure

Administrstrative Procedure ELECTRONIC WORKING COPY VERIF. DATE: INITIALS: DIVISION: Envirnment, Safety, Health and Quality FUNCTIONAL AREA: Occupatinal Safety and Health SME: Garrick Schmburg Page 1 f 13 APPROVED BY/DATE: Steve

More information

Extraction and Demonstration of Uterotonic Activity from the Root of Steganotaenia Araliacea Hochst

Extraction and Demonstration of Uterotonic Activity from the Root of Steganotaenia Araliacea Hochst Original Article Medical Jurnal f Zambia, Vl. 44, N.3: 125-132 (2017) Extractin and Demnstratin f Utertnic Activity frm the Rt f Stegantaenia Araliacea Hchst 1* 1 2 3 1 1 2 FM Gma, C Ezeala, J Nyirenda,

More information

AVAILABLE COPPER, ZINC, MANGANESE AND I RON STATUS OF RAJASTHAN SOILS

AVAILABLE COPPER, ZINC, MANGANESE AND I RON STATUS OF RAJASTHAN SOILS Annals f Arid Zne 30 (I) : 17-21, 1991 AVAILABLE COPPER, ZINC, ANGANESE AND I RON STATUS OF RAJASTHAN SOILS R.K. EHRA and B.L. BASER Department f Sil Science & Agril. Chemistry Rajasthan Cllege f Agriculture,

More information

UNIT 2: mapping bananas

UNIT 2: mapping bananas Oxfam Educatin www.xfam.rg.uk/educatin UNIT 2: mapping bananas Age range: 7-11 years Outline Learners will investigate sme f the cuntries where the bananas we eat in the UK are grwn. They will first lcate

More information

SQA-VISION VALIDATION REPORT

SQA-VISION VALIDATION REPORT Objective SQA-VISION VALIDATION REPORT T test the new cnvenience features f the SQA-Visin vs. the SQA-V and manual semen assessment: Swim-up Density Gradient Lngevity Vitality Mrphlgy Cunter Scanning Debris/Rund

More information

The Digestive System. May 16, The Digestive System.notebook

The Digestive System. May 16, The Digestive System.notebook 3 The Digestive System.ntebk The Digestive System THE BASIC CONCEPTS Animals btain energy by breaking fd mlecules int smaller pieces. The basic fuel mlecules are amin acids, lipids and carbhydrates. The

More information

* Manuscript received August 25, t Horticultural Research Section, CSIRO, Glen Osmond, South Australia.

* Manuscript received August 25, t Horticultural Research Section, CSIRO, Glen Osmond, South Australia. SUCROSE BREAKDOWN AND SYNTHESIS IN THE RIPENING GRAPE BERRY* By P. J. HARDyt Sucrse is the majr translcated sugar in the grapevine (Swansn and EIShishiny 1958), but in the berry glucse and fructse tgether

More information

Module 3. Chapter 5 Microbial Metabolism. Catabolic and Anabolic Reactions Metabolism Two general types of metabolic reactions: o :

Module 3. Chapter 5 Microbial Metabolism. Catabolic and Anabolic Reactions Metabolism Two general types of metabolic reactions: o : Mdule 3 Chapter 5 Micrbial Metablism Catablic and Anablic Reactins Metablism Tw general types f metablic reactins: : : Recall frm Chapter 2: Energy can be when bnds Energy can be when bnds Catablism Purpse

More information

Injury, Incident & Illness Procedure

Injury, Incident & Illness Procedure Injury, Incident & Illness Prcedure Injury / Incident Includes any child, adult, r emplyee injured n site. A first aid kit will be available at all times. It will be maintained in accrdance with criterin

More information

ESCHERICHIA COLI O157:H7

ESCHERICHIA COLI O157:H7 Fact Sheet N 125 July 1996 ESCHERICHIA COLI O157:H7 1. What is Escherichia cli O157:H7? Escherichia cli is a bacterium that is a cmmn inhabitant f the gut f warm blded animals, including man. Mst strains

More information

Infection Control. Three Ways Germs Are Spread Germs are spread in the environment three ways: direct contact, indirect contact, and droplet spread.

Infection Control. Three Ways Germs Are Spread Germs are spread in the environment three ways: direct contact, indirect contact, and droplet spread. Infectin Cntrl Infectin cntrl is preventing the spread f germs that cause illness and infectin. Infectin cntrl starts with understanding germs and hw they are spread. Abut Germs Everyne cmes in cntact

More information

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment r prphylaxis. Evidence supprting this guidance is detailed belw.

More information

Triumeq (abacavir, dolutegravir and lamivudine) Product Backgrounder for US Media

Triumeq (abacavir, dolutegravir and lamivudine) Product Backgrounder for US Media Triumeq (abacavir, dlutegravir and lamivudine) Prduct Backgrunder fr US Media What is Triumeq and wh is Triumeq fr? Triumeq (abacavir 600mg, dlutegravir 50mg and lamivudine 300mg) is the first dlutegravir-based

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information